glucagon-like-peptide agonists (Neurogen)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameglucagon-like-peptide agonists (Neurogen)
Drug Alias NameGLP-1 agonist program (Neurogen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurogen Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurogen Corp
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A